Valvular & structural heart disease

Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease

CirculationPublished Mechanistic study

Authors' conclusion

MFSD5 knockdown suppressing human valvular cell Lp(a) uptake and calcification, along with meta-analysis of MFSD5 variants associating with aortic stenosis

Study context

Population
Primary human valvular endothelial and interstitial cells; aortic stenosis genetic association
Comparison
MFSD5 inhibition vs no inhibition
Outcome
Lp(a) uptake and calcification; MFSD5 variants and AS
Methodological detailsligand-receptor capture mass spectrometry, genetic association analysis
  • Ligand-receptor capture mass spectrometry
  • Genetic association analysis

Main finding

As reported in the abstract

MFSD5 variants associated with AS (after multiple hypothesis testing)

P=0.027

Original publication

Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease. Circulation. Published 8 November 2023. doi:10.1161/circulationaha.123.066822

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.